Pharmacy Groups Urge Pilot Project Approach To AMP Disclosure

Given the relative novelty of Medicaid average manufacturer prices for multi-source drugs, the National Association of Chain Drug Stores suggests that a pilot program approach to disclosure would help ensure price data accuracy